¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pain tolerance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • organ tolerance dose
    ±â°ü°ßµõ¼±·®
  • oxygen tolerance
    »ê¼Ò³»¼º
  • self-tolerance
    1. ÀÚ°¡°ü¿ë 2. ÀÚ°¡³»¼º
  • abdominal colicky pain
    ±Þ°æ·Ãº¹Åë
  • anginal pain
    Çù½ÉÅëÁõ, °¡½¿Á¶ÀÓÅëÁõ
  • auditory pain
    û°¢ÅëÁõ
  • abdominal pain
    º¹Åë, ¹è¾ÎÀÌ
  • back pain
    µîÅëÁõ
  • birth pain
    ºÐ¸¸ÅëÁõ, »êÅë
  • bone pain
    »ÀÅëÁõ
  • boring pain
    ÂÅëÁõ, õÀÚÅë
  • breakthrough pain
    µ¹¹ßÅëÁõ
  • burning pain
    ÀÛ¿­Åë
  • colicky pain
    ±Þ°æ·ÃÅë
  • complex regional pain syndrome
    º¹ÇÕºÎÀ§ÅëÁõÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiating pain
    ¹æ»çÅë, ºÎê»ìÅëÁõ
  • referred pain
    ¿¬°üÅëÁõ
  • root pain
    ½Å°æ»Ñ¸®ÅëÁõ, ½Å°æ±ÙÅëÁõ
  • somatic pain
    ¸öÅëÁõ
  • spontaneous pain
    ÀÚ¹ßÅëÁõ
  • visceral pain
    ³»ÀåÅëÁõ, Àå±âÅëÁõ
  • pain spot
    ÅëÁõÁ¡
  • pain sense
    Åë°¢, ¾ÆÇ°¨°¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º°Ë»ç
  • high-dose tolerance
    Ç׿ø°ú·®Çã¿ë
  • high-zone tolerance
    Ç׿ø°ú·®Çã¿ë
  • immunologic tolerance
    ¸é¿ª°ü¿ë
  • induction tolerance
    ¸é¿ª°ü¿ëÀ¯¹ß
  • low-dose tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • low-zone tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • median tolerance limit
    ¹Ý¼ö»ýÁ¸ÇѰè³óµµ
  • metabolic tolerance
    ´ë»ç³»¼º
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • pharmacodynamic tolerance
    ¾à¿ªÇг»¼º
  • pressure tolerance
    ¾Ð¹Ú³»¼º
  • self-tolerance
    ÀÚ°¡°ü¿ë¼º
  • self tolerance
    ÀÚ±â¸é¿ªÇã¿ë
  • sitting tolerance
    ÁÂÀ§³»¼º, ¾ÉÀ½³»¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance test =GTT
    ´çºÎÇϰ˻ç(ÓØÝ¶ùÃËþÞÛ).
  • heat tolerance
    ³»¿­¼º(Ò±æðàõ).
  • heat tolerance
    ³»¿­¼º(ËÀËçËÛ).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(¡­Ò±àõãËúÐ).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(?ËÀËÛËàÌ´).
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º½ÃÇè.
  • high dose tolerance
    °ú·®°ü¿ë
  • high-zone tolerance
    °í¿ª°ü¿ë, Ç׿ø°ú·®°ü¿ë
  • immune tolerance
    ¸é¿ª°ü¿ë
  • immunologic tolerance
    ¸é¿ª°ü¿ë(Øóæ¹Î°é»)
  • immunologic tolerance
    ¸é¿ª°ü¿ë(¡­Î°é»)
  • immunological tolerance
    ¸é¿ª³»¼º.
  • induction, tolerance
    °ü¿ëÀ¯¹ß (¸é¿ª)
  • infectious tolerance
    Àü´Þ¼º ¸é¿ª°ü¿ë
  • insulin tolerance
    Àν¶¸°³»¼º.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross tolerance
    ±³Â÷¸é¿ª°ü¿ë
  • cross-tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • diabetes mellitus,oral glucose tolerance test
    °æ±¸´çºÎÇÏ °Ë»ç(ÌèÏ¢ÓØÝ¶ùà ËþÞÛ)
  • drug disposition tolerance
    ¾à¹°ºÐÇØ³»¼º.
  • drug tolerance
    ¾à¹°<¾àÁ¦>³»¼º.
  • drug tolerance
    ¾à¹°³»¼º(å·ÚªÒ±àõ).
  • exercise tolerance
    ¿îµ¿Çã¿ë´É(ê¡ÔÑúÉé»Òö).
  • exercise tolerance
    ¿îµ¿Çã¿ë´É.
  • exercise tolerance
    ¿îµ¿Çã¿ë´É
  • exercise tolerance test
    ¿îµ¿ºÎÇϰ˻ç(ê¡ÔÑݶùÃËþÞÛ).
  • exercise tolerance test
    ¿îµ¿ºÎÇϰ˻ç.
  • exercise tolerance test
    ¿îµ¿ºÎÇϰ˻ç
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè
  • fructose tolerance test
    ÇÁ¶ôÅ佺ºÎÇϽÃÇè.
  • galactose tolerance test
    °¥¶ôÅ佺ºÎÇÏ ½ÃÇè.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pain
    µ¿Åë, Åë°¢, ÁøÅë
  • pain clinic
    ÅëÁõÄ¡·á½Ç, µ¿ÅëÁø·á½Ç
  • pain sense
    Åë°¢
  • postprandial epigastric pain
    ½ÄÈĽɿͺε¿Åë
  • postprandial pain
    ½ÄÈļºÅëÁõ
  • pulsating pain
    ¹Úµ¿¼ºµ¿Åë
  • radiating pain
    ¹æ»çÅë
  • radicular pain
    ô¼ö½Å°æ±ÙÅë
  • retrosternal pain
    Èä°ñÈĹ浿Åë
  • rheumatic pain
    ·ù¸¶Æ¼½ºÅë(Áõ)
  • shooting pain
    Àü°ÝÅë
  • stabbing pain
    Â´Â µíÇÑ ¾ÆÇÄ, ÀÚ»óÇüµ¿Åë, ÀÚÅë
  • substernal pain
    Èä°ñÇϵ¿Åë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PT pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t...
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
LBP lipopolysaccharide-binding protein; low back pain; low blood pressure; lumbar back pain
MPDS mandibular pain dysfunction syndrome; myofascial pain dysfunction syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GTT Glucose Tolerance Test
GT Glucose tolerance
IVGTT I.v. glucose tolerance tests
ITI Immune tolerance induction
IGT Impaired Glucose Tolerance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • organ tolerance dose
    ±â°ü Çã¿ë·®, Àå±â Çã¿ë·®
  • pharmacodynamic tolerance
    ¾à¿ªÇÐÀû ³»¼º
  • poison tolerance
    µ¶¹° ³»¼º
    Áö¼ÓÀûÀÎ µ¶¼º ¹°Áú¿¡ ÀÇÇØ »ýü°¡ ±× µ¶¼º ¹°Áú¿¡ ÀúÇ×¼ºÀ» ³ªÅ¸³»´Â °Í.
  • tolerance
    ³»¾à¼º, ³»¼º, ³»¿ë·Â, Çã¿ë, °ü¿ë
    1. º¸Åë ¾à¹°À̳ª µ¶¹°ÀÇ ¸¹Àº »ç¿ë·®À» °ßµð¾î ³¾ ¼ö ÀÖ´Â ´É·Â. 2. ÈÄõÀûÀ¸·Î ȹµæµÈ ¾à¹° ³»¼º. ¹Ýº¹ÀûÀÎ µ¿·®ÀÇ »ç¿ë·®¿¡ ´ëÇÑ ¹ÝÀÀ¼ºÀÇ °¨¼Ò ȤÀº °°Àº ¹ÝÀÀÀ» ¾ò±â À§Çؼ­ Áõ°¡µÈ »ç¿ë·®À» ¿ä±¸ÇÏ´Â °Í.
  • tolerance span
    Àγ» ±â°£
  • tolerance to antimicrobial
    Ç×±ÕÁ¦ ³»¼º
  • tolerance to high altitude
    °í¼Ò ³»¼º
  • A delta pain fiber
    A µ¨Å¸ µ¿Åë ½Å°æ ¼¶À¯, A µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
  • a-delta pain fiber
    a-µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
    Á÷°æÀÌ 1-4§­ÀÎ ÅëÁõ Àü´Þ ½Å°æ ¼¶À¯ÀÌ´Ù. ¿¹¸®ÇÑ ÅëÁõÀ» Àü´ÞÇϸç, ¼ø°£ÀûÀÎ ÅëÁõÀ» ºü¸£°Ô Àü´ÞÇÑ´Ù.
  • abdominal pain
    º¹Åë
    º¹ºÎ ÂÊ¿¡¼­ ´À²¸Áö´Â ÅëÁõ, ºÒÆíÇÑ ´À³¦, ½ÉÇÑ °íÅë. ÁÖ·Î ¼ÒÈ­±â Áúȯ¿¡¼­ º¼ ¼ö ÀÖ´Â Áß¿äÇÑ Áõ»óÀ¸·Î¼­, ÀϹÝÀûÀ¸·Î ¾î´À °÷ÀÌ ¾ÆÇ°¡¿¡ µû¶ó Áø´ÜÀÌ °¡´ÉÇϹǷΠº¹ÅëÀÇ ºÎÀ§¸¦ Á¤È®È÷ ¾Ë¾Æ¾ß ÇÑ´Ù. ¶Ç ¾ÆÇÄÀÇ Á¤µµ¿Í ¾ÆÇ Çüŵµ Áø´ÜÀÇ ´Ü¼­°¡ µÈ´Ù. »ç¶÷¿¡ µû¶ó °¨¼ö¼ºÀÌ ´Ù¸¥µ¥, ÀϹÝÀûÀ¸·Î ½Å°æÁúÀûÀÎ »ç¶÷Àº ½ÉÇÏ°Ô ´À³¢´Â °æ¿ì°¡ ¸¹°í, ±× Áß¿¡´Â °úÀåÇØ¼­ Ç¥ÇöÇÏ´Â »ç¶÷µµ ÀÖ´Ù. ½ÉÇÑ º¹ÅëÀ» »êÅëÀ̶ó Çϸç, °£ÇæÀûÀ¸·Î ½Ã°£À» µÎ¾î µÇÇ®ÀÌÇÏ´Â °æ¿ì´Â ´ã¼®À̰ųª ½ÅÀå °á¼®À» ÀǽÉÇÒ ¼ö ÀÖ´Ù. ¸íÄ¡ ºÎ±ÙÀÌ °è¼Ó ¾ÆÇà ¶§´Â À§±Ë¾ç µîÀÇ Ãµ°øÀ̳ª º¹¸·¿° µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. ¶§·Î´Â ±â»ýÃæ¿¡ ÀÇÇÑ °Í, È÷½ºÅ׸®¿¡ ÀÇÇÑ º¹ÅëÀÇ ¹ßÀÛµµ ÀÖ´Ù. ¶ÇÇÑ º¹Åë¿¡ µû¸£´Â ´Ù¸¥ Áõ»óµµ ÁÖÀÇÇÏ¿© Ä¡·á¸¦ ÇÏ¿©¾ß Çϸç, ½ÉÇÑ º¹Åë°ú ÇÔ²² ¹ß¿­À̳ª ±¸Å並 ¼ö¹ÝÇÒ ¶§´Â ±ÞÈ÷ ÀÇ»çÀÇ Áø´ÜÀ» ¹Þ¾Æ¾ß ÇÑ´Ù. ±¸Å䳪 ¼³»ç°¡ °è¼ÓµÇ´Â °æ¿ì´Â Å»¼ö »óÅ·ΠµÇ¾î ¼îÅ©¸¦ ÀÏÀ¸Å°´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î ÀÔ¿ø Ä¡·á¸¦ ÇÏ¿©¾ß ÇÑ´Ù. ÅëÁõÀÌ µÐÇϰí Áö¼ÓÀûÀ¸·Î µû²ûµû²ûÇÏ°Ô ¾ÆÇ º¹ÅëÀº º¯ºñ³ª Àå³»¿¡ °¡½º°¡ Â÷ ÀÖÀ» ¶§ º¼ ¼ö ÀÖÀ¸¸ç, ¿Â¾ö¹ýÀ» ¾²¸é ÄèÀûÇØÁø´Ù. ÀϹÝÀûÀ¸·Î ÁøÅëÁ¦³ª À§Àå ¾àÀ» º¹¿ëÇÏ´Â Á¤µµ´Â º° ÁöÀåÀÌ ¾øÁö¸¸, ÅëÁõÀÌ ½ÉÇÒ ¶§´Â Áï°¢ ÀÇ»çÀÇ Áø´ÜÀÌ ÇÊ¿äÇÏ¸ç ¼³»çÁ¦´Â ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó »ç¿ëÇÏ¿©¾ß ÇÑ´Ù. ¶ÇÇÑ ºÎÀ§º°·Î º¸¸é, ¸íÄ¡ ºÎ±ÙÀÇ °ÝÅëÀº À§Àå Áúȯ¿¡ ¸¹°í, ±Þ¼º À§¿°¡¤À§±Ë¾ç¡¤À§ ¾Ï¡¤À§ Çϼö ¿Ü¿¡ ½ÊÀÌÁöÀå ±Ë¾ç¡¤º¹¸·¿°¡¤´ã¼® ¹ßÀÛ¡¤±Þ¼º ÃéÀå¿°¡¤ÃéÀå ±«»ç µîÀ» ºñ·ÔÇÏ¿© ½É±Ù°æ»öÀÇ °æ¿ì¿¡µµ °¡²û º¼ ¼ö ÀÖ´Ù. ¿ìȾº¹ÀÇ ÅëÁõÀº ´ã¼®¡¤´ã³¶¿°À» ºñ·ÔÇÏ¿© °£À̳ª ½ÉÀåÀÇ º´ ¶Ç´Â È丷¿°À̳ª Æó·Å µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. ÁÂȾº¹ÀÇ °æ¿ì´Â ºñÀå
  • acute pain
    ±Þ¼º ÅëÁõ, ±Þ¼º µ¿Åë
    1. À¯¹ß ÀÎÀÚ³ª ¿øÀÎ ÀÎÀÚµéÀÌ Á¤»óÀ¸·Î µÇ´Âµ¥ ÇÊ¿äÇÑ ½Ã°£À̳ª Á¤»óÀûÀÎ Ä¡À¯ ±â°£ ³»¿¡ Á¦ÇÑµÇ¾î ³ªÅ¸³ª´Â ºÒÄèÇÑ °¨°¢. ÀüÅëÀûÀÎ Á¤ÀÇ¿¡ ÀÇÇϸé 6°³¿ù ¹Ì¸¸ÀÇ ±â°£ÀÌ´Ù. 2. ª°í ºñ±³Àû ½ÉÇÑ ÇüÅÂÀÇ µ¿Åë.
  • acute pathologic pain
    ±Þ¼º º´¸®Àû µ¿Åë
  • ascending pain pathway
    »óÇà µ¿Åë Àü´Þ·Î
  • atypical tooth pain
    ºñÁ¤Çü Ä¡Åë, ºñÁ¤Çü¼º Ä¡Åë
    µ¿ÀǾî=idio
  • auditory pain
    û°¢ ÅëÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
nonresponder tolerance Lack of immune response to antigen. Theories of tolerance induction include clonal deletion and clonal anergy. In clonal deletion, the actual clone of cells is eliminated whereas in clonal anergy the cells are present but nonfunctional.
Synonym: immunological tolerance, immunotolerance, nonresponder tolerance.
(05 Mar 2000)
drug tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from drug resistance wherein a human, animal, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug.
(12 Dec 1998)
immune tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (foetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
(12 Dec 1998)
immunological tolerance <immunology> Specific unresponsiveness to antigen. Self tolerance is a process occurring normally early in life due to suppression of self reactive lymphocyte clones.
Tolerance to foreign antigens can be induced in adult life by exposure to antigens under conditions in which specific clones are suppressed. Note that tolerance is not the same as immunological unresponsiveness, since the latter may be very non-specific as in immunodeficiency states.
(18 Nov 1997)
immunologic high dose tolerance Induction of tolerance by exposure to large amounts of protein antigens.
(05 Mar 2000)
immunologic tolerance Lack of immune response to antigen. Theories of tolerance induction include clonal deletion and clonal anergy. In clonal deletion, the actual clone of cells is eliminated whereas in clonal anergy the cells are present but nonfunctional.
Synonym: immunological tolerance, immunotolerance, nonresponder tolerance.
(05 Mar 2000)
impaired glucose tolerance Blood glucose (sugar) levels higher than normal but not high enough to be called diabetes. People with impaired glucose tolerance may or may not develop diabetes.
Other names (no longer used) for impaired glucose tolerance are borderline, subclinical, chemical, or latent diabetes.
(30 Mar 1998)
individual tolerance Tolerance to a drug that the person has never received before.
(05 Mar 2000)
oral lactose tolerance test A test for lactose deficiency; the plasma glucose response to an oral lactose load is measured as in the (oral) glucose tolerance test.
(05 Mar 2000)
test, glucose tolerance After fasting, a specific amount (100 grams) of glucose is given by mouth, and the blood levels of this sugar are measured every hour. Normally, the blood glucose should return to normal within 2 to 2 1/2 hours. The gtt is considered a classic test of carbohydrate metabolism. It is much used in the diagnosis of diabetes. The gtt depends on a number of factors including the ability of the intestine to absorb glucose, the power of the liver to take up and store glucose, the capacity of the pancreas to produce insulin, and the amount of active insulin.
(12 Dec 1998)
tolerance 1. The ability to endure unusually large doses of a drug or toxin.
2. Acquired drug tolerance, a decreasing response to repeated constant doses of a drug or the need for increasing doses to maintain a constant response.
Origin: L. Tolerantia
(18 Nov 1997)
tolerance dose The largest dose of a remedy that can be accepted without the production of injurious symptoms.
(05 Mar 2000)
exercise tolerance The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an exercise test.
(12 Dec 1998)
frustration tolerance The level of an individual's ability to withstand frustration without developing inadequate modes of response, such as "going to pieces" emotionally.
(05 Mar 2000)
abdominal pain Sensation of discomfort, distress, or agony in the abdominal region.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á